Onkologie und Versorgung in Fach- und Publikationsmedien

Mucci LA et al (2016) Familial risk and heritability of cancer among twins in Nordic countries. JAMA 315(1):68–76 Deutsche Krebsgesellschaft (Hrsg) (2012) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Zuckschwerdt, München Lethaby A et al (2013) Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev 2013(12):10 Fritz H et al (2013) Black cohosh and breast cancer: A systematic review. Integr Cancer Ther 25: (epub ahead of print) Leach ML, Moore V (2012) Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 12(9):CD007244 Drewe J et al (2015) A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus 4:65 Adelson KB et al (2005) Treatment of hot flushes in breast and prostate cancer. Expert Opin Pharmacother 6(7):1095–1106 Deutsche Gesellschaft für Radioonkologie (DEGRO) (2015) S2e-Leitlinie 052/014: Supportive Maßnahmen in der Radioonkologie. Version 1.2. Stand 02/2015. http://www.degro.org/dav/html/leitlinien/LLSupportivtherapie.pdf. Zugegriffen: 18.4.2016 Water-Jel Technologies LLC. http://www.waterjel.com/. Zugegriffen: 18.4.2016 Manas A et al (2015) Topical R1 and R2 prophylactic treatment of acute radiation dermatitis in squamous cell carcinoma of the head and neck and breast cancer patients treated with Chemoradiotherapy. Eplasty 15:e25 Water-Jel Technologies International. https://www.radiotherapytreatment.com/de/clinical-evaluation/. Zugegriffen: 18.4.2016 Häfner MF et al (2013) Prophylaxis of acute radiation dermatitis with an innovative FDA-approved two-step skin care system in a patient with head and neck cancer undergoing a platin-based radiochemotherapy: a case report and review of the literature. Dermatology 227(2):171–174 Ali-Seyed MA et al (2015) Betulinic acid: recent advances in chemical modifications, effective delivery, and molecular mechanisms of a promising anticancer therapy. Chem Biol Drug Des : (Epub ahead of print) Memorial Sloan Kettering Cancer Center. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/chaga-mushroom. Zugegriffen: 18.4.2016 Zhang DM et al (2015) Betulinic acid and its derivatives as potential antitumor agents. Med Res Rev 35(6):1127–1155 Arbeitsgemeinschaft Gynäkologische Onkologie e. V. (AGO) Empfehlungen gynäkologische Onkologie Kommission Mamma. http://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/maerz2015/de/2015D_14_Nebenwirkungen_der_Therapie.pdf. Zugegriffen: 18.4.2016 Maninger N et al (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 30:65–91 Peixoto C et al (2014) . The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review. Curr Drug Targets 15(9):901–914 Dor BR et al (2015) DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA’s antidepressant action. Psychopharmacology (Berl) 232(18):3375–3383. doi:10.1007/s00213-015-3991-1 Veronese N et al (2015) Serum dehydroepiandrosterone sulfate and incident depression in the elderly: the Pro.V.A. study. Am J Geriatr Psychiatry 23(8):863–871 Labrie F (2015) All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. J Steroid Biochem Mol Biol 145:133–138 Caufriez A et al (2013) Effects of a 3‑week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study. Clin Endocrinol (Oxf) 79(5):716–724 Campagnoli C et al (2013) Postmenopausal breast cancer, androgens, and aromatase inhibitors. Breast Cancer Res Treat 139(1):1–11